1. Home
  2. CADL vs BGT Comparison

CADL vs BGT Comparison

Compare CADL & BGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$10.55

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo BlackRock Floating Rate Income Trust

BGT

BlackRock Floating Rate Income Trust

N/A

Current Price

$10.99

Market Cap

318.8M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CADL
BGT
Founded
1999
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
318.8M
IPO Year
2021
2004

Fundamental Metrics

Financial Performance
Metric
CADL
BGT
Price
$10.55
$10.99
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$19.00
N/A
AVG Volume (30 Days)
1.2M
120.3K
Earning Date
05-14-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
58.62
N/A
EPS
N/A
N/A
Revenue
$125,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$10.22
52 Week High
$14.00
$12.44

Technical Indicators

Market Signals
Indicator
CADL
BGT
Relative Strength Index (RSI) 42.84 49.59
Support Level $4.91 $10.83
Resistance Level $11.36 $11.13
Average True Range (ATR) 0.69 0.08
MACD -0.26 -0.01
Stochastic Oscillator 5.54 45.95

Price Performance

Historical Comparison
CADL
BGT

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About BGT BlackRock Floating Rate Income Trust

Blackrock Floating Rate Income Trust is a diversified closed-end management investment company. Its investment objective is to provide a high level of current income. The company, as a secondary objective, also focuses on preservation of capital to the extent consistent with its primary objective of high current income. The Trust seeks to achieve its investment objectives by investing in worl-wide portfolio of floating rate securities, including investing a substantial amount in U.S. and non-U.S. senior secured floating rate loans (Senior Loans), made to corporate and other business entities.

Share on Social Networks: